ToxiPlex – Mycotoxins Test from a one blood serum sample

To buy the Toxiplex test please email info@aonm.org or call 03331 210 305

ORDER ONLINE

Toxiplex Example Results: Sample Report 1, Sample Report 2

—————

Mycotoxins are a large group of compounds found in foods. They are derived from certain fungi moulds and exhibt a range of toxicological characteristics.

Fungi, and their metabolites, contaminate raw materials that are usually used in the preparation of human food and animal feed. The main crops affected are grains (rice, wheat, rye, barley, corn, soybeans), dried fruits, nuts, coffee and spices. Despite efforts, up to 60%–80% of food crops are contaminated by mycotoxins.

Exposure to mycotoxins are not always the result of food consumption, with studies exploring that exposure can also happen in working or living environments. Mycotoxicosis can cause acute and chronic health effects to humans and livestock via ingestion, inhalation and contact with the skin, as well as through entering the lymphatic system and blood stream. While acute effects manifest within 72 h ofexposure, chronic effects may take months, years, or even decades. They harm the macrophage system, impair protein synthesis, intensify the response to bacterial endotoxin, and inhibit particle clearance of the lungs. Symptoms of mycotoxicosis are based on the type of mycotoxin, the age, sex, and health of victims, the mycotoxin concentration, and the length of exposure. The impact of mycotoxins on human health depends on the type of toxin, its metabolism, pharmacokinetics and the accumulation of the mycotoxin, exposure conditions and the age, gender, immune system and health status of the exposed individual.

ToxiPlex provides a quantitative and qualitative in-vitro assay for mycotoxins and detects aflatoxin B1 (AFB1), deoxynivalenol (DON), fumonisin (FUM), ochratoxin A (OTA) and zearalenone (ZEA) in human serum.

ToxiPlex provides a direct immunochemical detection of mycotoxins. It detects the presence of mycotoxins rather than the antibody response to mycotoxins. Thus, the test is suitable for people with immunodeficiency and chronic diseases.

 


 

References:

Habschied, K.; Kanižai Šari´c, G.; Krstanovi´c, V.; Mastanjevi´c, K. Mycotoxins—Biomonitoring and Human Exposure. Toxins 2021, 13, 113. https://doi.org/10.3390/ toxins13020113
Arce-López, B.; Lizarraga, E.; Vettorazzi, A.; González-Peñas, E. Human Biomonitoring of Mycotoxins in Blood, Plasma and Serum in Recent Years: A Review. Toxins 2020, 12, 147. https://doi.org/10.3390/toxins12030147
Awuchi, C.G.; Ondari, E.N.; Nwozo, S.; Odongo, G.A.; Eseoghene, I.J.; Twinomuhwezi, H.; Ogbonna, C.U.; Upadhyay, A.K.; Adeleye, A.O.; Okpala, C.O.R. Mycotoxins’ Toxicological Mechanisms Involving Humans, Livestock and Their Associated Health Concerns: A Review. Toxins 2022, 14, 167. https:// doi.org/10.3390/toxins14030167